首页 | 本学科首页   官方微博 | 高级检索  
检索        

SEPT7基因抑制人胶质瘤细胞系U251MG侵袭的研究
引用本文:徐嵩,贾志凡,黄强,王广秀,张安玲,刘晓智,周旋,许鹏,浦佩玉.SEPT7基因抑制人胶质瘤细胞系U251MG侵袭的研究[J].中华医学遗传学杂志,2008,25(3):262-267.
作者姓名:徐嵩  贾志凡  黄强  王广秀  张安玲  刘晓智  周旋  许鹏  浦佩玉
作者单位:天津医科大学总医院神经病学研究所神经肿瘤实验室,300052
基金项目:国家自然科学基金,天津市高等学校科技发展基金计划项目,天津市科技发展基金 
摘    要:目的 研究SEPT7基因对人胶质瘤细胞系U251MG侵袭的抑制作用及其可能的分子机制.方法 以腺病毒为载体转导SEPT7(rAd5-SEFF7)入U251人脑胶质瘤细胞系;Transwell法和3-D Matrigel法观察U251胶质瘤细胞侵袭能力的变化,划痕实验和2-D Matrigel法观察细胞迁移能力的变化.应用蛋白印记检测MMP2,MMP9,MT1-MMP,TIMP1和TIMP2的表达变化,蛋白印记和免疫荧光检测整合素αvβ3的表达,以及应用激光扫描共聚焦显微镜观察细胞骨架蛋白tubulin-α结构的变化.结果 转染SEPT7后U251MG细胞的侵袭和迁移能力明显受到抑制、细胞MMP2、MMP9、MT1-MMP和整合素αvβ3的表达下调、TIMP1和TIMP2的表达则上调;肿瘤细胞的微管蛋白tubulin-α结构出现了重新分布,发生了扭曲及聚集现象,接近于正常的非肿瘤细胞的tubulin-α结构.结论 SEPT7基因可以抑制胶质瘤细胞的侵袭和迁移能力,其分子机制可能通过逆转MMPs/TIMPs的失衡状态,降低整合素αvβ3的表达,以及改变细胞骨架tubulin-α的结构而实现的.SEPT7可作为基因治疗胶质瘤的重要候选基因.

关 键 词:胶质瘤  侵袭  SEPT7基因  基因治疗

Study On the anti-invasion effect of SEPT7 gene for U251MG glioma cell in vitro
XU Song,JIA Zhi-fan,HUANG Qiang,WANG Guang-xiu,ZHANG An-ling,LIU Xiao-zhi,ZHOU Xuan,XU Peng,PU Pei-yu.Study On the anti-invasion effect of SEPT7 gene for U251MG glioma cell in vitro[J].Chinese Journal of Medical Genetics,2008,25(3):262-267.
Authors:XU Song  JIA Zhi-fan  HUANG Qiang  WANG Guang-xiu  ZHANG An-ling  LIU Xiao-zhi  ZHOU Xuan  XU Peng  PU Pei-yu
Institution:Laboratory of Neuro-oncology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, 300052 People's Republic of China.
Abstract:OBJECTIVE: To study the anti-invasion effect of SEPT7 gene on U251MG glioma cells and its possible molecular mechanism. METHODS: Recombinant adenovirus vector carrying SEPT7 gene (rAd5-SEPT7) was transduced to human glioma cell line U251MG, and empty adenovirus vector was used as control. Tumor invasion was examined by Transwell method and 3 D-Matrigel assay, and tumor cell migration by wound-healing method and 2 D-Matrigel assay. Three major molecular events associated with cell motility and migration, including changes of expression in MMP2, MMP9, MT1-MMP, TIMP1 and TIMP2, the alteration of integrin alpha(v)beta(3) expression, and the structural change of cytoskeleton protein, tubulin-alpha, in U251 cells transduced with rAd5-SEPT7 were studied by Western blotting, immunofluorescence and laser scanning confocal microscope, respectively. RESULTS: The invasive and migratory capabilities of cells transduced with rAd5-SEPT7 were inhibited. The expression of extracellular matrix metalloproteinases MMP-2, MMP-9, MT1-MMP and integrin alpha(v)beta(3) was significantly decreased, while the expression of matrix metalloproteinase inhibitor TIMP1, TIMP2 was upregulated. Intracellular cytoskeleton protein-tubulin-alpha in U251 cells exhibited prominent morphological changes which including the appearance of distortion and aggregation resulting from redistribution of tubulin-alpha, and this feature of alteration was similar to the tubulin-alpha structure in normal non-tumor cells. CONCLUSION: SEPT7 gene can inhibit the invasion and migration ability of U251 glioma cells. Its molecular mechanism may include that SEPT7 gene reverses the imbalanced state of MMPs/TIMPs, downregulates the expression of integrin alpha(v)beta(3) and alters the structure of tubulin-alpha of U251MG glioma cells. It is suggested that SEPT7 gene could be a good candidate for gene therapy of gliomas.
Keywords:gliomas  invasion  SEPT7 gene  gene therapy
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号